Market Research Reports and Industry Reports

Asia-Pacific Genetic Testing Market Outlook to 2024

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Asia-Pacific Genetic Testing Market Outlook to 2024

Summary

GlobalDatas new report, Asia-Pacific Genetic Testing Market Outlook to 2024, provides key market data on the Asia-Pacific Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

2
1.List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.What Is This Report About? 6
2.2 Genetic Testing Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Genetic Testing Market, Asia-Pacific 8
3.Genetic Testing Market, Asia-Pacific, Revenue ($m), 2010-2024 8
3.2 Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), 2010-2024 10
3.3 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2010-2017 12
3.4 Genetic Testing Market, Asia-Pacific, Revenue ($m), 2017-2024 14
3.5 Genetic Testing Market, Asia-Pacific, Company Share by Revenue ($m), 2017 16
4 Genetic Testing Market, Australia 18
4.Genetic Testing Market, Australia, Revenue ($m), 2010-2017 18
4.2 Genetic Testing Market, Australia, Revenue ($m), 2017-2024 20
4.3 Genetic Testing Market, Australia, Distribution Share by Revenue ($m), 2017 22
4.4 Genetic Testing Market, Australia, Company Share by Revenue ($m), 2017 23
5 Genetic Testing Market, China 25
5.Genetic Testing Market, China, Revenue ($m), 2010-2017 25
5.2 Genetic Testing Market, China, Revenue ($m), 2017-2024 27
5.3 Genetic Testing Market, China, Distribution Share by Revenue ($m), 2017 29
5.4 Genetic Testing Market, China, Company Share by Revenue ($m), 2017 30
6 Genetic Testing Market, India 32
6.Genetic Testing Market, India, Revenue ($m), 2010-2017 32
6.2 Genetic Testing Market, India, Revenue ($m), 2017-2024 34
6.3 Genetic Testing Market, India, Distribution Share by Revenue ($m), 2017 36
6.4 Genetic Testing Market, India, Company Share by Revenue ($m), 2017 37
7 Genetic Testing Market, Japan 39
7.Genetic Testing Market, Japan, Revenue ($m), 2010-2017 39
7.2 Genetic Testing Market, Japan, Revenue ($m), 2017-2024 41
7.3 Genetic Testing Market, Japan, Distribution Share by Revenue ($m), 2017 43
7.4 Genetic Testing Market, Japan, Company Share by Revenue ($m), 2017 44
8 Genetic Testing Market, South Korea 46
8.Genetic Testing Market, South Korea, Revenue ($m), 2010-2017 46
8.2 Genetic Testing Market, South Korea, Revenue ($m), 2017-2024 48
8.3 Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), 2017 50
8.4 Genetic Testing Market, South Korea, Company Share by Revenue ($m), 2017 51
9 Overview of Key Companies in Asia-Pacific Genetic Testing Market 53
9.F. Hoffmann-La Roche Ltd 53
9.1.Company Overview 53
9.2 PerkinElmer Inc 53
9.2.Company Overview 53
9.3 Abbott Laboratories 53
9.3.Company Overview 53
9.4 Qiagen NV 54
9.4.Company Overview 54
9.5 Hologic Inc 54
9.5.Company Overview 54
10 Genetic Testing Market Pipeline Products 55
1Recent Developments 58
11.Corporate Communications 58
11.1.Oct 29, 2017: George Church, a world-renowned scientist, joins the scientific advisory board of CloudHealth Medical Group to advise on the strategic development of their "pan-omics" direct to consumer platform 58
11.1.2 Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 58
11.1.3 Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer 59
11.1.4 Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 59
11.2 Financial Announcements 60
11.2.Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 60
11.2.2 Jul 27, 2017: Genetic Technologies: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017 61
11.2.3 May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update 63
11.2.4 Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update 64
11.2.5 Jan 31, 2017: Vela Diagnostics, a turnkey manufacturer for IVD NGS and PCR workflow solutions announces its 2016 results and highlights 65
11.2.6 Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update 66
11.3 Legal And Regulatory 66
11.3.Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 66
11.4 Other Significant Developments 67
11.4.Oct 30, 2017: Genetic Technologies Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017 67
11.4.2 Oct 17, 2017: WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data 69
11.4.3 Sep 25, 2017: Baylor Genetics Partners With Rainbow Genomics Offering Adult Wellness Screening and High-Risk Cancer Exome Sequencing Tests in Asian Pacific 70
11.4.4 Aug 25, 2017: Genetic Technologies Announces Comprehensive Review of Strategic Alternatives 70
11.4.5 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers 71
11.4.6 Aug 16, 2017: FDA Accepts Supplemental Biologics License Application and Grants Priority Review for ADCETRIS (Brentuximab Vedotin) in Cutaneous T-Cell Lymphoma 71
11.4.7 Apr 10, 2017: CloudHealth Genomics Makes Chinas First Sequencing Data Available Using Illuminas NovaSeq 6000 73
11.4.8 Mar 07, 2017: Vela Genomics Launches NGS Clinical Interpretation and Reporting 73
11.4.9 Jan 23, 2017: Oxford BioDynamics enters into pilot project with EpiFit to analyse the effect of fitness regimes using EpiSwitch 73
11.4.10 Jan 04, 2017: GrandOmics Biosciences Expands Investment in PacBios Sequel Systems for Precision Medicine Initiative 74
11.5 Product News 75
11.5.Oct 23, 2017: TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation 75
11.5.2 Jun 02, 2017: Macrogen Launches Special Promotion on Exome Sequencing to Celebrate Their 20th Anniversary 75
11.5.3 Apr 26, 2017: Seegene Unlocks the Door to the Next Level of the Real-time PCR Business 76
11.5.4 Mar 09, 2017: New test to monitor the success of bone marrow transplants 77
11.5.5 Feb 23, 2017: CloudHealth Genomics Presents their Unique Market Strategy and ImmuneSeq Panel for both Cancer and Non-Cancer Immunotherapies 77
12 Appendix 79
12.Research Methodology 80
12.1.Coverage 80
12.1.2 Secondary Research 80
12.1.3 Primary Research 81
12.1.4 Market Modeling and Forecasting 82
12.1.5 Company Share Analysis 83
12.1.6 Distribution Share Analysis 84
12.1.7 Benchmarking 84
12.2 GlobalData Consulting 84
12.3 Contact Us 85
12.4 Disclaimer 85

List Of Tables

1.1 List of Tables
Table 1: Genetic Testing Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2010-2024 9
Table 2: Genetic Testing Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2010-2024 11
Table 3: Genetic Testing Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2010-2017 13
Table 4: Genetic Testing Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2017-2024 15
Table 5: Genetic Testing Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2017 17
Table 6: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 19
Table 7: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 21
Table 8: Genetic Testing Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 22
Table 9: Genetic Testing Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 24
Table 10: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 11: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 28
Table 12: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 29
Table 13: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2017 31
Table 14: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 33
Table 15: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Table 16: Genetic Testing Market, India, Distribution Share by Revenue ($m), USD Constant, 2017 36
Table 17: Genetic Testing Market, India, Company Share by Revenue ($m), USD Constant, 2017 38
Table 18: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 19: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 20: Genetic Testing Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2017 43
Table 21: Genetic Testing Market, Japan, Company Share by Revenue ($m), USD Constant, 2017 45
Table 22: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 47
Table 23: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Table 24: Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 50
Table 25: Genetic Testing Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 52
Table 26: Genetic Testing Market Pipeline Products 55
Table 27: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 82

Asia-Pacific Arc Fault Circuit Interrupter (AFCI) Market Report 2017

This report studies the Arc Fault Circuit Interrupter market status and outlook of Asia-Pacific and major countries, from angles of players, regions, product types and end industries; this report analyzes

USD 4000View Report

Asia-Pacific Zippered Tool Bags Market Report 2017

In this report, the Asia-Pacific Zippered Tool Bags market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

USD 4000View Report

Global Direct-to-consumer Genetic Testing Market Size, Status and Forecast 2022

This report studies the global Direct-to-consumer Genetic Testing market, analyzes and researches the Direct-to-consumer Genetic Testing development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

USD 3300View Report

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureGlobalDatas new report, Canada In Vitro

USD 5995View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 5995
  • Site Licence    USD 11990
  • Enterprise Wide Licence    USD 17985
$ 5995

Reports Details

Published Date : Dec 2017
No. of Pages :85
Country :Asia-Pacific
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube